To the Editor.—
The treatment of keratoacanthoma (KA) with fluorouracil cream administered by the intralesional1,2 and topical routes at concentrations of 20%3 and 5%4,5 has been reported. When treating these lesions without histologic confirmation, the following criteria are suggested to preclude the misdiagnosis of squamous cell carcinoma: (1) characteristic morphology of the keratoacanthoma, (2) history of growth of the lesion to its ultimate size within four to six weeks, and (3) prompt response of the lesion to fluorouracil treatment with at least 60% to 70% involution during a two-week treatment period.4 We describe a patient with such a lesion that initially responded to fluorouracil therapy only to recur three weeks after completion of therapy. An excisional biopsy specimen at that time revealed a poorly differentiated squamous cell carcinoma.
Report of a Case.—
A 76-year-old man presented with a three- to four-week history of a rapidly growing
Cobb MW, Pellegrini AE. Squamous Cell Carcinoma Following Fluorouracil-Responsive `Keratoacanthoma'. Arch Dermatol. 1987;123(8):987–988. doi:10.1001/archderm.1987.01660320027002
Customize your JAMA Network experience by selecting one or more topics from the list below.